细胞周期调控基因与POLD1基因转录活性的相关性研究
|
摘要
DNA复制调控是细胞周期调控的一个核心事件。在DNA合成过程中,细胞周期通过Cyclin、CDK、CKI及其它相关蛋白对DNA复制复合体进行复杂的活性调控,因而保证每个细胞周期中DNA只能精确地复制一次。此外,细胞周期还控制着复制体相关基因的表达。DNA合成时,DNA聚合酶δ(polδ)与PCNA、RFC构成复合体,进而完成导前导链与后滞链的延伸。真核细胞polδ由4个亚基组成,POLD1基因编码了催化亚基,其mRNA及蛋白水平在G1/S期达到高峰,但是至今尚不清楚细胞周期通过何种通路调控POLD1启动子活性。
本研究运用细胞周期同步化及荧光素酶报告基因测定了人乳腺癌MCF7细胞中POLD1启动子在细胞周期不同时相的活性。结果显示启动子活性随着细胞周期进程而变化,在早S期最高。瞬时共转染实验发现,随着E2F1的积累,POLD1启动子活性逐渐升高,表现出剂量依赖效应。E2F1最大能将POLD1启动子活性提高到对照组的2.98倍。运用染色体免疫共沉淀(ChIP)技术证明E2F1能够与POLD1启动子结合。
为进一步确定调控POLD1表达的细胞周期相关因子,应用质粒pXJ41-neo、pEGFP-p53、pXJ41-p21、pXJ41-as-CDK2、pXJ41-as-CyclinE、pXJ41-as-CDK4及pXJ41-as-Cyclin D1分别转染MCF7细胞,分别筛选得到稳定细胞系。结果表明增强p53或p21的表达,抑制CDK2或Cyclin E的表达都能抑制POLD1启动子活性;而抑制CDK4或Cyclin D1的表达对启动子活性没有明显影响。随着CDK2或Cyclin E表达量的降低,POLD1启动子活性逐渐降低,表现出剂量依赖效应。抑制CDK2的表达能将POLD1启动子活性降低到对照组的50%左右,而抑制Cyclin E的表达能降低到30%。此外,对POLD1启动子的抑制作用还表现出时间依赖效应,一般在转染24小时后才能表现出较强的抑制,而转染48小时后的抑制最强。
用pEGFP-p53重组质粒瞬时转染MCF7细胞,RT-PCR结果显示由于p53表达增强,POLD1基因mRNA水平降低。染色体免疫共沉淀和荧光素酶实验证明p53在细胞内直接结合POLD1启动子而抑制其活性,且这种抑制具有时间依赖效应和剂量依赖效应。间接免疫荧光和荧光定位实验均显示p53在G1期进入细胞核而在S期和G2期则被转运至细胞质。但是荧光素酶实验显示p53在细胞周期各时相都能抑制POLD1启动子活性,表现出细胞周期非依赖性特点。
本研究还发现,在p21表达增强的细胞中,POLD1 mRNA及蛋白水平都有所下降。p21高表达后能抑制POLD1启动子活性,且这种抑制具有剂量依赖效应,抑制最强时,启动子活性只相当于对照组的27%。同时,这种抑制也具有时间依赖效应,在转染后36小时后才能达到最大抑制。p21还可以通过影响E2F1的活性而消除E2F1对POLD1启动子的促进作用。利用p21的截取突变体和点突变体发现p21对POLD1启动子的抑制作用不依赖于Cyclin/CDK复合体或PCNA。利用一系列POLD1启动子突变体发现,p21对POLD1启动子的抑制是通过位于启动子+29～+33和+44～+48位置的CDE/CHR元件实现的。突变部分或全部的该元件后,p21几乎不能抑制启动子活性。这些结果说明p21能够以较为复杂的方式抑制POLD1启动子活性。
本研究首次系统探讨了细胞周期重要调控因子对POLD1基因启动子活性的调控作用,确定出E2F1、CDK2、Cyclin E、p53和p21对POLD1启动子活性的影响及作用方式。这些结果有助于理解细胞周期进程中DNA复制的调控机理。
DNA replication regulation is one of the core events of cell cycle regulation. During DNA synthesis, cell cycle system controls the activity of DNA replication complex(RC), through Cyclins, CDKs, CKIs and other relative proteins, as ensures that DNA is exactly doubled only once in one cell cycle. Furthermore, the expression of genes relative to RC assembling is regulated by cell cycle system as well. To synthesize DNA, DNA polymeraseδ(polδ), PCNA and RFC consist of a complex, completing the elongation of leading and lagging strands. In eukaryotic cells, polδcontains four subunits, and the catalytic subunit is encoded by POLD1 gene, whose mRNA and protein levels reach peak at G1/S phase. However, how the cell cycle system regulates POLD1 promoter activity is unknown so far.
In this study, cell cycle synchronization and luciferase reporter system were used to investigate POLD1 promoter activity, in human breast cancer cell MCF7, in different phases of cell cycle. Results showed that the promoter activity altered following the cell cycle progression, and was the highest at early S phase. Transient cotransfection assay revealed that the gradually accumulation of E2F1 caused an ascendant promoter activity, suggesting a doze-dependent stimulation effect. Furthest, E2F1 could raise the activity of POLD1 promoter up to 2.98 folds, compared with control group. Besides, a directly binding of E2F1 to POLD1 promoter was displayed by chromatin immunoprecipitation (ChIP) assay.
In search of cell cycle relative factors, which were able to regulate the expression of POLD1 gene, variety of plasimids, including pXJ41-neo, pEGFP-p53, pXJ41-p21, pXJ41-as-CDK2, pXJ41-as-CyclinE, pXJ41-as-CDK4 and pXJ41-as-Cyclin D1, was transfected into MCF7 cells, respectively, and stable cell lines were obtained. Results indicated that POLD1 promoter activity was inhibited by over-expressed p53 or p21, as well as by low-expressed CDK2 or Cyclin E, while not affected by low-expressed CDK4 or Cyclin D1. The promoter activity of POLD1 was declined with the degradation of CDK2 or Cyclin E, suggesting a doze-dependent effect. Compared with control group, POLD1 promoter activity was deceased to 50% by the inhibition of CDK2 expression, and 30% by the inhibition of Cyclin E. Furthermore, the inhibition represented a time course-dependent effect also, and the distinct inhibition occurred at 24 hours after transfection and peaked at 48 hours.
PEGFP-p53 plasmid was transient transfected into MCF7 cells, and RT-PCR revealed a decrease of POLD1 mRNA level, as a result of the enhancement of p53 expression. Using ChIP and luciferase assay, it was demonstrated that p53 bound to POLD1 promoter in vivo, exerting doze- and time course-dependent inhibition. Immunofluoresence assay and fluorescent observation showed that p53 was recruited into nucleus at G1 phase and excluded to cytoplasm at S and G2 phases. However, POLD1 promoter activity was suppressed at each phase of cell cycle, suggesting a cell cycle independent character.
It was also shown in this study that in the cells overexpressing p21, mRNA and protein levels of POLD1 were decreased. P21 could inhibit POLD1 promoter activity by doze-dependent manner, decreasing the promoter activity to 27%, and time course-dependent manner, as well, reaching a maximum suppression at 36 hours after transfection. Additionally, the promotion effect resulting from E2F1 was reduced by p21. Truncation and site mutations of p21 were employed and it was revealed that the inhibition effect of p21 on POLD1 promoter did not reckon on Cyclin/CDK complex or PCNA. Through a series of mutants derived from POLD1 promoter, the judgment was demonstrated that p21 inhibited POLD1 promoter through the CDE/CHR element, localized at +29～+33 and +44～+48. If the element was mutated partly or entirely, p21 could hardly inhibit POLD1 promoter. These results displayed that p21 suppressed POLD1 promoter through complicated way.
This study systemically investigated regulation of POLD1 promoter activity through important cell cycle factors, for the first time. It was identified that E2F1, Cyclin E, CDK2, p53 and p21 participated in the regulation of POLD1 promoter activity, and the regulatory mode was explored. These results would contribute to the insight into the DNA replication mechanism regulated by cell cycle.
本研究运用细胞周期同步化及荧光素酶报告基因测定了人乳腺癌MCF7细胞中POLD1启动子在细胞周期不同时相的活性。结果显示启动子活性随着细胞周期进程而变化,在早S期最高。瞬时共转染实验发现,随着E2F1的积累,POLD1启动子活性逐渐升高,表现出剂量依赖效应。E2F1最大能将POLD1启动子活性提高到对照组的2.98倍。运用染色体免疫共沉淀(ChIP)技术证明E2F1能够与POLD1启动子结合。
为进一步确定调控POLD1表达的细胞周期相关因子,应用质粒pXJ41-neo、pEGFP-p53、pXJ41-p21、pXJ41-as-CDK2、pXJ41-as-CyclinE、pXJ41-as-CDK4及pXJ41-as-Cyclin D1分别转染MCF7细胞,分别筛选得到稳定细胞系。结果表明增强p53或p21的表达,抑制CDK2或Cyclin E的表达都能抑制POLD1启动子活性;而抑制CDK4或Cyclin D1的表达对启动子活性没有明显影响。随着CDK2或Cyclin E表达量的降低,POLD1启动子活性逐渐降低,表现出剂量依赖效应。抑制CDK2的表达能将POLD1启动子活性降低到对照组的50%左右,而抑制Cyclin E的表达能降低到30%。此外,对POLD1启动子的抑制作用还表现出时间依赖效应,一般在转染24小时后才能表现出较强的抑制,而转染48小时后的抑制最强。
用pEGFP-p53重组质粒瞬时转染MCF7细胞,RT-PCR结果显示由于p53表达增强,POLD1基因mRNA水平降低。染色体免疫共沉淀和荧光素酶实验证明p53在细胞内直接结合POLD1启动子而抑制其活性,且这种抑制具有时间依赖效应和剂量依赖效应。间接免疫荧光和荧光定位实验均显示p53在G1期进入细胞核而在S期和G2期则被转运至细胞质。但是荧光素酶实验显示p53在细胞周期各时相都能抑制POLD1启动子活性,表现出细胞周期非依赖性特点。
本研究还发现,在p21表达增强的细胞中,POLD1 mRNA及蛋白水平都有所下降。p21高表达后能抑制POLD1启动子活性,且这种抑制具有剂量依赖效应,抑制最强时,启动子活性只相当于对照组的27%。同时,这种抑制也具有时间依赖效应,在转染后36小时后才能达到最大抑制。p21还可以通过影响E2F1的活性而消除E2F1对POLD1启动子的促进作用。利用p21的截取突变体和点突变体发现p21对POLD1启动子的抑制作用不依赖于Cyclin/CDK复合体或PCNA。利用一系列POLD1启动子突变体发现,p21对POLD1启动子的抑制是通过位于启动子+29～+33和+44～+48位置的CDE/CHR元件实现的。突变部分或全部的该元件后,p21几乎不能抑制启动子活性。这些结果说明p21能够以较为复杂的方式抑制POLD1启动子活性。
本研究首次系统探讨了细胞周期重要调控因子对POLD1基因启动子活性的调控作用,确定出E2F1、CDK2、Cyclin E、p53和p21对POLD1启动子活性的影响及作用方式。这些结果有助于理解细胞周期进程中DNA复制的调控机理。
DNA replication regulation is one of the core events of cell cycle regulation. During DNA synthesis, cell cycle system controls the activity of DNA replication complex(RC), through Cyclins, CDKs, CKIs and other relative proteins, as ensures that DNA is exactly doubled only once in one cell cycle. Furthermore, the expression of genes relative to RC assembling is regulated by cell cycle system as well. To synthesize DNA, DNA polymeraseδ(polδ), PCNA and RFC consist of a complex, completing the elongation of leading and lagging strands. In eukaryotic cells, polδcontains four subunits, and the catalytic subunit is encoded by POLD1 gene, whose mRNA and protein levels reach peak at G1/S phase. However, how the cell cycle system regulates POLD1 promoter activity is unknown so far.
In this study, cell cycle synchronization and luciferase reporter system were used to investigate POLD1 promoter activity, in human breast cancer cell MCF7, in different phases of cell cycle. Results showed that the promoter activity altered following the cell cycle progression, and was the highest at early S phase. Transient cotransfection assay revealed that the gradually accumulation of E2F1 caused an ascendant promoter activity, suggesting a doze-dependent stimulation effect. Furthest, E2F1 could raise the activity of POLD1 promoter up to 2.98 folds, compared with control group. Besides, a directly binding of E2F1 to POLD1 promoter was displayed by chromatin immunoprecipitation (ChIP) assay.
In search of cell cycle relative factors, which were able to regulate the expression of POLD1 gene, variety of plasimids, including pXJ41-neo, pEGFP-p53, pXJ41-p21, pXJ41-as-CDK2, pXJ41-as-CyclinE, pXJ41-as-CDK4 and pXJ41-as-Cyclin D1, was transfected into MCF7 cells, respectively, and stable cell lines were obtained. Results indicated that POLD1 promoter activity was inhibited by over-expressed p53 or p21, as well as by low-expressed CDK2 or Cyclin E, while not affected by low-expressed CDK4 or Cyclin D1. The promoter activity of POLD1 was declined with the degradation of CDK2 or Cyclin E, suggesting a doze-dependent effect. Compared with control group, POLD1 promoter activity was deceased to 50% by the inhibition of CDK2 expression, and 30% by the inhibition of Cyclin E. Furthermore, the inhibition represented a time course-dependent effect also, and the distinct inhibition occurred at 24 hours after transfection and peaked at 48 hours.
PEGFP-p53 plasmid was transient transfected into MCF7 cells, and RT-PCR revealed a decrease of POLD1 mRNA level, as a result of the enhancement of p53 expression. Using ChIP and luciferase assay, it was demonstrated that p53 bound to POLD1 promoter in vivo, exerting doze- and time course-dependent inhibition. Immunofluoresence assay and fluorescent observation showed that p53 was recruited into nucleus at G1 phase and excluded to cytoplasm at S and G2 phases. However, POLD1 promoter activity was suppressed at each phase of cell cycle, suggesting a cell cycle independent character.
It was also shown in this study that in the cells overexpressing p21, mRNA and protein levels of POLD1 were decreased. P21 could inhibit POLD1 promoter activity by doze-dependent manner, decreasing the promoter activity to 27%, and time course-dependent manner, as well, reaching a maximum suppression at 36 hours after transfection. Additionally, the promotion effect resulting from E2F1 was reduced by p21. Truncation and site mutations of p21 were employed and it was revealed that the inhibition effect of p21 on POLD1 promoter did not reckon on Cyclin/CDK complex or PCNA. Through a series of mutants derived from POLD1 promoter, the judgment was demonstrated that p21 inhibited POLD1 promoter through the CDE/CHR element, localized at +29～+33 and +44～+48. If the element was mutated partly or entirely, p21 could hardly inhibit POLD1 promoter. These results displayed that p21 suppressed POLD1 promoter through complicated way.
This study systemically investigated regulation of POLD1 promoter activity through important cell cycle factors, for the first time. It was identified that E2F1, Cyclin E, CDK2, p53 and p21 participated in the regulation of POLD1 promoter activity, and the regulatory mode was explored. These results would contribute to the insight into the DNA replication mechanism regulated by cell cycle.
引文
[1] Nishitani H, Lygerou Z. Control of DNA replication licensing in a cell cycle. Genes to Cells, 2002, 7(6): 523-534
[2] Stevaux O, Dyson NJ. A revised picture of the E2F transcriptional network and RB function. Curr Opin Cell Biol, 2002 , 14(6): 684-691
[3] Bandura JL, Calvi BR. Duplication of the genome in normal and cancer cell cycles. Cancer Biology & Therapy, 2002, 1(1):8-13
[4] Burgers, P M, Bambara, R A, Campbell, J L, et al. Revised nomenclature for eukaryotic DNA polymerases. 1990, Eur J Biochem, 191: 617–618
[5] Peter M J, Burgers, Eugene V, et al. Eukaryotic DNA polymerases: proposal for a revised nomenclature. J Biol Chem, 2001, 276: 43487 – 43490
[6] Polina V S, Katarayna B, Thomas A K. Functions of eukaryotic DNA polymerase. Science of Aging Knowledge Environment, 2003, 8: 1-11
[7] Byrnes J, Downey K M, Black V L, et al. A new mammalian DNA polymerase with 3’ to 5’ exonuclease activity: DNA polymerase delta. Biochemistry, 1976, 15: 2817-2823
[8] Lee M Y, Tan C K, So A G, et al. Purification of deoxyribonucleic acid polymerase delta from calf thymus: Patial characterization of physical properties. Biochemistry, 1980, 19: 2096-2101
[9] Shevelev I V, Hubscher U. The 3' 5' exonucleases. Nat Rev Mol Cell Biol, 2002, 3(5): 364-376
[10] Lee M Y, Jiang Y, Zhang S J et al. Characterization of human DNA polymerase δ and its immunological relationships with DNA polymerase α and ε. J Biol Chem, 1991, 266: 2423-2429
[11] Lee M Y, Tan C-K, Downey K M and So A G. Further studies on calf thymus DNA polymerase δ purified to homogeneity by a new procedure. Biochemistry, 1984, 23: 1906-1913
[12] Hughes P, Tratner I, Ducoux M, Piard K, et al. Isolation and identification of the third subunit of mammalian DNA polymerase by PCNA-affinity chromatography of mouse FM3A cell extracts. Nucleic Acids Res, 1999, 27: 2108-2114
[13] Liu L, Mo J, Rodriguez-Belmonte E M, et al. Identification of a forth subunit of mammalian DNA polymerase. J. Biol. Chem, 2000, 275: 18739-18744
[14] Podust V N, Chang L S, Ott R, et al. Reconstitution of human DNA polymerasedelta using recombinant baculoviruses: the p12 subunit potentiates DNA polymerizing activity of the four-subunit enzyme. J Biol Chem, 2002, 277: 3894-3901
[15] Li H, Xie B, Zhou Y, et al. Functional roles of p12, the fourth subunit of the human DNA polymerase delta .J Biol Chem, 2006, 10.1074/jbc.M600322200
[16] Peter M J, Burgers and Gerik K J. Structure and processivity of two forms of Saccharomyces cerevisiae DNA polymerase . J Biol Chem, 1998, 273: 19756-19762
[17] Johansson E, Majka J, Burgers P M. Structure of DNA polymerase delta from Saccharomyces cerevisiae. J Biol Chem, 2001, 276: 43824 - 43828
[18] MacNeill S A, Moreno S, Reynolds N, et al. The fission yeast Cdc1 protein, a homologue of the small subunit of DNA polymerase delta,binds to Po13 and Cdc27. EMBO J, 1996, 15:4613-4628
[19] Zuo S, Bermudez V, Zhang G, et al. Structure and Activity Associated with Multiple Forms of Schizosaccharomyces pombe DNA Polymerase . J Biol Chem, 2000, 275: 5153-5162
[20] Reynolds N, Warbrick E, Fantes P A, et al. Essential interaction between the fission yeast DNA polymerase delta subunit Cdc27 and Pcn1 (PCNA) mediated through a C-terminal p21(Cip1)-like PCNA binding motif . EMBO J, 2000, 19: 1108-1118
[21] Hindges R, Hubscher U. DNA polymerase delta, an essential enzyme for DNA transactions. Biol Chem, 1997, 378:345-362
[22] Brautigam C A, Steitz T A. Structural and functional insights provided by crystal structures of DNA polymerases and their substrate complexes. Curr Opin Struct Biol, 1998, 8: 54-63
[23] Yang C L, Chang L S, Zhang P, et al. Molecular cloning of the cDNA for the catalytic subunit of human DNA polymerase delta. Nucleic Acids Res, 1992, 20: 735 – 745
[24] Hao H, Jiang Y, Zhang S J,et al. Structural and functional elationships of human DNA polymerases. Chromosome, 1998, 102: S121-S127
[25] Zhang S J, Zeng X R, Zhang P, et al. A conserved region in the amino terminus of DNA polymerase delta is involved in proliferating cell nucleat antigen binding. J Biol Chem, 1995, 270: 7988-7992
[26] Hindges R, Hubscher U. Cloning, chromosomal location, and interspeciesinteraction of mouse DNA polymerase delta amall subunit (PolD2). Genomics, 1997, 44: 45-51
[27] Hughes, Tratner I, Ducoux M, et al. Isolation and identification of the third subunit of mammalian DNA polymerase delta by PCNA-affinity chromatography of mouse FM3A cell extracts. Nucleic Acids Res, 1999, 27(10): 2108-2114
[28] Hughes D A, MacNeill S A, Fantes P A. Molecular cloning and sequence analysis of cdc27+ required for the G2-M transition in the fission yeast Schizosaccharomyces prombe. Mol Gen Genet, 1992, 231: 401-410
[29] Gerik K J, Li X, Pautz A, et al. Characterization of the two small subunits of Saccharomyces cerevisiae DNA polymerase delta. J Biol Chem, 1998, 273: 19747-19755
[30] Mo J, Liu L, Leon A, et al. Evidence that DNA polymerase delta isolated by inmmunoaffinity chromatography exhibits high-molecular weight characteristics and is associated with the KIAA0399 protein and RPA. Biochemistry, 2000, 39: 7245-7254
[31] MacNeill S A, Baldacci G, Burgers P M, et al. A unifiednomenclature for the subunits of eukaryotic DNA polymerase δ. Trends in Biochemical Sci, 2001, 26(1): 16-7
[32] Wang S and Stillman B. Anatomy of a DNA replication fork revealed by reconstitution of SV 40 DNA replication in vitro. Nature, 1994, 369: 207-212
[33] Brown W C, Duncan J A and Campbell J L. Purification and characterization of the Saccharomyces cerevisiae DNA polymerase δ overproduced in Escherichia coli. J Biol Chem, 1993, 268: 982-990
[34] Macneill S A, Moreno S, Reynolds N, et al. The fission yeast Cdc1 protein, a homologue of the small subunit of DNA polymerase δ binds to Pol3 and Cdc27. EMBO J, 1996,15: 4613-4628.
[35] Zlotkin T, Kaufmann G, Jiang Y, et al. DNA polymerase epsilon may be dispensable for SV40- but not cellular-DNA replication. EMBO J, 1996, 15: 2298-2305
[36] Budd M E, Campbell J L. Interrelationships between DNA repair and DNA replication. Mutat Res. 2000, 451(1-2): 241-255
[37] Longley M J, Pierce A J and Modrich P. DNA polymerase delta is required for human mismatch repair in vitro. J Biol Chem, 1997, 272: 10917-10921
[38] Jin Y H, Obert R, Burgers P M, et al. The exonuclease of DNA polymerase delta can substitute for the 5' flap endonuclease Rad27/Fen1 in processing Okazaki fragments and preventing genome instability. Proc Natl Acad Sci, USA, 2001, 98: 5122-5127
[39] Morrison A and Sugino A. The 3'-5' exonucleases of both DNA polymerases delta and epsilon participate in correcting errors of DNA replication in Saccharomyces cerevisiae. Mol Gen Genet, 1994, 242: 289-296
[40] Zeng X R, Jiang Y, Zhang S J, et al. DNA polymerase delta is involved in the cellular response to UV damage in human cells. J Biol Chem, 1994, 269: 13748-13751
[41] Shivji M K, Podust V N, Hubecher U, et al. Nucleotide excision repair DNA synthesis by DNA polymerase epsilon in the presence of PCNA, RFC, and RPA. Biochemistry, 1995, 34: 5011-5017
[42] Budd M E and Campbell J L. DNA polymerases required for repair of UV-induced damage in Saccharomyces cerevisiae. Mol Cell Biol, 1995, 15: 2173-2179
[43] Giot L, Chanet R, Simon M, et al. Involvement of the yeast DNA polymerase delta in DNA repair in vivo. Genetics, 1997, 146: 1239-1251
[44] Blank A, Kim B and Loeb L A. DNA polymerase delta is required for base excision repair of DNA methylation damage in Saccharomyces cerevisiae. Proc Natl Acad Sci, 1994, USA, 91: 9047-9051
[45] Fortini P, Pascucci B, Parlanti E, et al. Different DNA polymerases are involved in the short- and long-patch base excision repair in mammalian cells. Biochemistry, 1998, 37: 3575-3580
[46] Diede S J and Gottschling D E. Telomerase-mediated telomere addition in vivo requires DNA primase and DNA polymerases alpha and delta. Cell, 1999, 99: 723-733
[47] Maloisel L, Bhargava J and Roeder G. S. A Role for DNA Polymerase in Gene Conversion and Crossing Over During Meiosis in Saccharomyces cerevisiae . Genetics, 2004, 167: 1133 – 1142
[48] Loeb L A, Springgate C F, Battula N, Errors in DNA replication as a basis of malignant changes. Cancer Res. 1974, 34: 2311–2321
[49] Loeb L A, Loeb K R and Anderson J P. Multiple mutations and cancer. PNAS, 2003, 100: 776 – 781
[50] Chang L S, Zhao L, Zhu L, et al. Structure of the gene for the catalytic subunit of human DNA polymerase delta (POLD1). Genomics, 1995, 28(3): 411-9
[51] Chung, Zhang J, Tan C, et al. Primary Structure of the Catalytic Subunit of Human DNA Polymerase and Chromosomal Location of the Gene. PNAS, 1991, 88: 11197 – 11201
[52] Flohr T, Dai J C, Buttner J, et al. Detection of mutations in the DNA polymerase delta gene of human sporadic colorectal cancers and colon cancer cell lines. Int J Cancer, 1999, 80(6): 919-29
[53] Goldsby R E, Lawrence N A, Hays L E, et al. Defective DNA polymerase-delta proofreading causes cancer susceptibility in mice. Nat Med, 2001, 7(6): 638-639
[54] Robert E. Goldsby, Laura E. et al. High incidence of epithelial cancers in mice deficient for DNA polymerase proofreading. PNAS, 2002, 99: 15560 – 15565
[55] Martin G M. Genetics and the pathobiology of ageing. Philos Trans R Soc London B Biol Sci, 1997, 352, 1773-1780
[56] Szekely A M, Chen Y H, ZhangC, et al. Werner protein recruits DNA polymerase to the nucleolus. PNAS, 2000, 97: 11365- 11370
[57] Kamath-Loeb A S, Loeb L A, Johansson E, et al. Interactions between the Werner Syndrome helicase and DNA polymerase specifically facilitate copying of tetraplex and hairpin structures of the d (CGG)n trinucleotide repeat sequence. J Biol Chem, 2001, 276: 16439–16446
[58] Tsurimoto T, Shinozaki A, Yano M, et al. Human Werner helicase interacting protein1 (WRNIP1) functions as a novel modulator for DNA polymerase delta. Genes Cells, 2005, 10(1): 13 - 22
[59] Liu L, Rodriguez-Belmonte E M, Mazloum N, et al. Identification of a novel protein, PDIP38, that interacts with the p50 subunit of DNA polymerase delta and proliferating cell nuclear antigen. J Biol Chem, 2003, 278: 10041-10047. Epub 2003, 09.
[60] Xie B, Li H, Wang Q, et al. Further characterization of human DNA polymerase interacting protein 38. J Biol Chem, 2005, 280: 22375 – 22384
[61] Liao G., Huang J, Fixman E D, et al. The epstein-barr virus replication protein BBLF2/3 provides an origin-tethering function through interaction with the zinc finger DNA binding protein ZBRK1 and the KAP-1 corepressor. J Virol, 2005,79, 245-256
[62] Dell'era P, Nicoli S, Peri G, et al. FGF2-induced upregulation of DNA polymerase-delta p12 subunit in endothelial cells. Oncogene, 2005, 24, 1117-1121
[63] Zhao L and Chang L S. The human POLD1 gene: identifictaion of an upstream activitor sequence, activation by Sp1 and Sp3, and cell cycle regulation. J Biol Chem, 1997, 272: 4869 – 4882
[64] Li B and Lee M Y W. Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1. J Biol Chem, 2001, 276: 29729 – 29739
[65] Bell S P and Dutta A et al. DNA replication in eukaryotic cells. Annu Rev Biochem, 2002, 71:333-374
[66] G Maga and Hubscher U. DNA replication machinery: functional characterization of a complex containing DNA polymerase alpha, DNA polymerase delta, and replication factor C suggests an asymmetric DNA polymerase dimer. Biochemistry, 1996, 35: 5764-5777
[67] Arezi B and Kuchta R D. Eukaryotic DNA primase. Trends Biochem Sci, 2000, 25: 572–576
[68] Hübscher U, Maga G and Spadari S. Eukaryotic DNA polymerases. Annu Rev Biochem, 2002, 71:133–163
[69] Takada-Takayama R, Tada S, Hanaoka F, et al. Peptide mapping of the four subunits of the mouse DNA polymerase alpha-primase complex. Biochem Biophys Res Commun, 1990, 170: 589-595
[70] Takada-Takayama R, Suzuki M, Enomoto T, et al. Purification and characterization of mouse DNA polymerase alpha devoid of primase activity. FEBS Lett, 1990, 273: 27-30
[70] Smith R W and Nasheuer H P et al. Control of complex formation of DNA polymerase alpha-primase and cell-free DNA replication by the C-terminal amino acids of the largest subunit p180. FEBS Lett, 2002, 527: 143-146
[72] Mizuno T, Yamagishi K, Miyazawa H, et al. Molecular architecture of the mouse DNA polymerase α-primase complex. Mol Cell Biol, 1999, 19: 7886 – 7896
[73] Ott R D, Rehfuess C, Podust V N, et al.Role of the p68 subunit of human DNA polymerase-primase in simian virus 40 DNA replication. Mol Cell Biol, 2002, 22: 5669 – 5678
[74] Mizuno T, Ito N, Yokoi M, et al. The second-largest subunit of the mouse DNA polymerase α-primase complex facilitates both production and nuclear translocation of the catalytic subunit of DNA polymeraseα. Mol Cell Biol, 1998, 18:3552–3562
[75] Mizuno T, Okamoto T, Yokoi M, et al. Identification of the nuclear localization signal of mouse DNA primase: nuclear transport of p46 subunit is facilitated by interaction with p54 subunit. J Cell Sci, 1996, 109: 2627–2636
[76] Maga G and Hübscher U. Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci, 2003, 116: 3051 – 3060
[77] H Xu, P Zhang, L Liu, and MY Lee. A novel PCNA-binding motif identified by the panning of a random peptide display library. Biochemistry, 2001, 40(14): 4512-4520
[78] Ogura T and Wilkinson A J. AAA+ superfamily ATPases: common structure-diverse function. Genes Cells, 2001, 6, 575–597
[79] Mossi R and Hubscher U. Clamping down on clamps and clamp loaders—the eukaryotic replication factor C. Eur. J. Biochem., 1998, 254, 209–216
[80] Shiomi Y, Usukura J, Masamura Y, et al. ATP-dependent structural change of the eukaryotic clamp-loader protein, replication factor C. Proc Natl Acad Sci, USA , 2000, 97: 14127–14132
[81] Shiomi Y, Shinozaki A, Sugimoto K, et al. The reconstituted human Chl12-RFC complex functions as a second PCNA loader. Genes Cells, 2004, 9(4): 279 – 290
[82] Bermudez V P, Lindsey-Boltz L A, Cesare A J, et al. Loading of the human 9–1–1 checkpoint complex onto DNA by the checkpoint clamp loader hRad17-replication factor C complex in vitro. Proc Natl Acad Sci, USA, 2003, 100: 1633–1638
[83] Kanellis P, Agyei R and Durocher D. Elg1 Forms an Alternative PCNA-Interacting RFC Complex Required to Maintain Genome Stability. Curr Biol, 2003, 13: 1583–1595
[84] McConnell M, Miller H, Mozzherin D J, et al. The mammalian DNA polymerase delta-- proliferating cell nuclear antigen--template-primer complex: molecular characterization by direct binding. Biochemistry, 1996, 35: 8268-8274
[85] O’Day C, Burgers P M J and Taylor J S. PCNA induced DNA synthesis past cis-syn and trans-syn-l thymine dimers by calf thymus DNA polymerase δ in Vitro. Nucleic Acids Research, 1992, 20: 5403-5406
[86] Zhang P, Sun Y, Hsu H, et al. The interdomain connector loop of human PCNA is involved in a direct interaction with human polymerase . J Biol Chem. 1998, 273: 713-719
[87] Zhang P, Mo J Y, Perez A, et al. Direct interaction of proliferating cell nuclear antigen with the p125 catalytic subunit of mammalian DNA polymerase . J Biol Chem, 1999, 274: 26647-26653
[88] Ducoux M, Urbach S, Baldacci G, et al. Mediation of proliferating cell nuclear antigen (PCNA)-dependent DNA replication through a conserved p21Cip1-like PCNA-binding motif present in the third subunit of human DNA polymerase . J Biol Chem, 2001, 276: 49258 – 49266
[89] Lu X, Tan C K, Zhou J Q, et al. Direct interaction of proliferating cell nuclear antigen with the small subunit of DNA polymerase . J Biol Chem, 2002, 277: 24340 - 24345
[90] Li H, Xie B, Zhou Y, et al. Functional roles of p12, the fourth subunit of the human DNA polymerase delta. J Biol Chem, 2006, 10.1074/jbc.M600322200
[91] Waga S and Stillman B. Anatomy of a DNA replication fork revealed by reconstitution of SV40 DNA replication in vitro. Nature, 1994, 369(6477): 207-212
[92] Szuts D, Kitching L, Christov C, et al. RPA is an initiation factor for human chromosomal DNA replication. Nucleic Acids Research, 2003, 31(6): 1725-1734
[93] Maga G, Stucki M, Spadari S, et al. DNA polymerase switching: I. Replication factor C displaces DNA polymerase alpha prior to PCNA loading. J Mol Biol, 2000, 295(4): 791-801
[94] Mossi R, Keller R C, Ferrari E, et al. DNA polymerase switching: II. Replication factor C abrogates primer synthesis by DNA polymerase α at a critical length. J Mol Biol, 2000, 295(4): 803-814
[95] Murante R S, Rumbaugh J A, Barnes C J, et al. Calf RTH-1 Nuclease Can Remove the Initiator RNAs of Okazaki Fragments by Endonuclease Activity. J Biol Chem, 1996, 271: 25888 – 25897
[96] Rumbaugh J A, Murante R S, Shi S, et al. Creation and Removal of Embedded Ribonucleotides in Chromosomal DNA during Mammalian Okazaki Fragment Processing. J Biol Chem, 1997, 272: 22591 - 22599
[97] Zhu F X, Biswas E E and Biswas S B. Purification and characterization of theDNA polymerase alpha associated exonuclease: the RTH1 gene product. Biochemistry, 1997, 36(20): 5947-5954
[98] Turchi J J, Huang L, Murante R S, et al. Enzymatic Completion of Mammalian Lagging-Strand DNA Replication. PNAS, 1994, 91: 9803 - 9807
[99] Maga G, Villani G, Tillement V, et al. Okazaki fragment processing: Modulation of the strand displacement activity of DNA polymerase by the concerted action of replication protein A, proliferating cell nuclear antigen, and flap endonuclease-1. PNAS, 2001, 98: 14298 - 14303
[100] 张艳丽,杨克恭,陈松森. 真核DNA复制机制的研究进展. 生命的化学, 2 0 0 0, 2 0(4): 156-158
[101] Erlandsson F, Linnman C, Ekholm S, et al. A detailed analysis of cyclin A accumulation at the G(1)/S border in normal and transformed cells. Exp Cell Res, 2000, 259(1): 86-95
[102] Pagano M, Pepperkok R, Verde F, et al. Cyclin A is required at two points in the human cell cycle. EMBO J, 1992, 11: 961 – 971
[103] Coverley D, Laman H and Laskey R A. Distinct roles for cyclins E and A during DNA replication complex assembly and activation. Nature Cell Biology,2002, 4: 523-528
[104] Cook J G, Park C H, Burke T W, et al. Analysis of Cdc6 function in the assembly of mammalian prereplication complexes. Proc Natl Acad Sci U S A. 2002, 99(3):1347-1352. Epub 2002 Jan 22
[105] Frouin I, Montecucco A, Biamonti G, et al. Cell cycle-dependent dynamic association of cyclin/CDK complexes with human DNA replication proteins. EMBO J, 2002, 21: 2485 – 2495
[106] Kim T Y and Kaelin W G. Differential Control of Transcription by DNA-bound Cyclins. Mol Biol Cell, 2001, 12: 2207 – 2217
[107] Sellers W R and Kaelin W G. pRB as a modulator of transcription. Biochim Biophys Acta, 1996, 1288(1): M1-5
[108] Bell S P and Dutta A. DNA replication in eukaryotic cells. Annu Rev Biochem, 2002, 71: 333-374
[109] Din S, Brill S J, Fairman M P, et al. Cell-cycle-regulated phosphorylation of DNA replication factor A from human and yeast cells. Genes & Dev, 1990, 4: 968 - 977
[110] Dutta A and Stillman B. cdc2 family kinases phosphorylate a human cell DNAreplication factor, RPA, and activate DNA replication. EMBO J, 1992, 11: 2189 – 2199
[111] Binz S K, Lao Y, Lowry D F, et al. The phosphorylation domain of the 32-kDa subunit of replication protein A (RPA) modulates RPA-DNA interactions: evidence for an intersubunit interaction. J Biol Chem, 2003, 278(37): 35584 – 35591
[112] VassinV M, Wold M S and Borowiec J A. Replication protein A (RPA) phosphorylation prevents RPA association with replication centers. Mol Cell Biol, 2004, 24(5): 1930 – 1943
[113] Dehde S, Rohaldy G, Schub O, et al. Two immunologically distinct human DNA polymerase alpha-primase subpopulations are involved in cellular DNA replication. Mol Cell Biol, 2001, 21, 2581-2593
[114] Voitenleitner C, Rehfuess C, HilmesM, et al. Cell cycle-dependent regulation of human DNA polymerase -primase activity by phosphorylation. Mol Cell Biol, 1999, 19: 646 – 656
[115] Ott R D, Rehfuess C, Podust V N, et al. Role of the p68 subunit of human DNA polymerase {alpha}-primase in simian virus 40 DNA replication. Mol Cell Biol, 2002, 22: 5669-5678
[116] Voitenleitner C, Fanning E and Nasheuer H P. Phosphorylation of DNA polymerase alpha-primase by cyclin A-dependent kinases regulates initiation of DNA replication in vitro. Oncogene , 1997, 14: 1611-1615
[117] Schub O, Rohaly G, Smith R W P, et al. Multiple phosphorylation sites of DNA polymerase alpha-primase cooperate to regulate the initiation of DNA replication in vitro. J Biol Chem, 2001, 276: 38076 - 38083
[118] Koundrioukoff S, Jónsson Z O, Hasan S, et al. A Direct interaction between proliferating cell nuclear antigen (PCNA) and CDK2 targets PCNA-interacting proteins for phosphorylation. J Biol Chem, 2000, 275: 22882 – 22887
[119] Munshi A, Cannella D, Brickner H, et al. Cell cycle-dependent phosphorylation of the large subunit of replication factor C (RF-C) leads to its dissociation from the RF-C complex. J Biol Chem, 2003, 278: 48467-48473
[120] Salles-Passador I, Munshi A, Cannella D, et al. Phosphorylation of the PCNA binding domain of the large subunit of replication factor C on Thr506 by cyclin-dependent kinases regulates binding to PCNA. Nucleic Acids Res, 2003, 31: 5202-5211
[121] Zeng X R, Hao H, Jiang Y, et al. Regulation of human DNA polymerase delta during the cell cycle. J Biol Chem, 1994, 269: 24027 – 24033
[122] Wu S M, Zhang P, Zeng X R, et al. Characterization of the p125 subunit of human DNA polymerase and its deletion mutants: interaction with cyclin-dependent kinase-cyclins. J Biol Chem, 1998, 273: 9561 - 9569
[123] Bashir T, H?rlein R, Rommelaere J, et al. Cyclin A activates the DNA polymerase -dependent elongation machinery in vitro: A parvovirus DNA replication model. PNAS, 2000, 97: 5522 - 5527
[124] Henneke G, Koundrioukoff S, Hubscher U. Phosphorylation of human Fen1 by cyclin-dependent kinase modulates its role in replication fork regulation. Oncogene, 2003, 22(28): 4301-4313
[125] Henneke G, Koundrioukoff S and Hübscher U. Multiple roles for kinases in DNA replication. EMBO Rep, 2003, 4: 252 – 256
[126] Ferrari G, Rossi R, Arosio D, et al. Cell cycle-dependent phosphorylation of human DNA ligase I at the cyclin-dependent kinase sites. J Biol Chem, 2003, 278: 37761 - 37767
[127] Kalma Y, Marash L, Lamed Y, et al. Expression analysis using DNA microarrays demonstrates that E2F-1 up-regulates expression of DNA replication genes including replication protein A2. Oncogene, 2001, 20:1379-1387
[128] Izumi M, Yokoi M, Nishikawa N S, et al. Transcription of the catalytic 180-kDa subunit gene of mouse DNA polymerase alpha is controlled by E2F, an Ets-related transcription factor, and Sp1. Biochim Biophys Acta, 2000, 1492: 341-352
[129] Nishikawa N S, Izumi M, Uchida H, et al. Cloning and characterization of the 5'-upstream sequence governing the cell cycle-dependent transcription of mouse DNA polymerase 68 kDa subunit gene Nucleic Acids Research, 2000, 28, 1525-1534
[130] Matsuo K, Shintani S, Tsuji T, et al. p12DOC-1, a growth suppressor, associates with DNA polymerase /primase. FASEB J, 2000, 14: 1318 – 1324
[131] Takemura M, Yamamoto T, Kitagawa M, et al. Stimulation of DNA polymerase alpha activity by cdk2-phosphorylated Rb protein. Biochem Biophys Res Commun, 2001, 282: 984-990
[132] Huang P. Excision of mismatched nucleotides from DNA: a potentialmechanism for enhancing DNA replication fidelity by the wild-type p53 protein. Oncogene, 1998, 17: 261-270
[133] Kuhn C, Muller F, Melle C, et al. Surface plasmon resonance measurements reveal stable complex formation between p53 and DNA polymerase alpha. Oncogene, 1999, 18: 769-774
[134] Melle C and Nasheuer H P. Physical and functional interactions of the tumor suppressor protein p53 and DNA polymerase α-primase. Nucleic Acids Res, 2002, 30: 1493 – 1499
[135] Krucher N A, Zygmunt A, Mazloum N, et al. Interaction of the retinoblastoma protein (pRb) with the catalytic subunit of DNA polymerase delta (p125). Oncogene, 2000, 19: 5464-5470
[136] Morris G F, Bischoff J R and Mathews M B. Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53. Proc Natl Acad Sci USA, 1996, 93: 895 – 899
[137] Wang L, Li M, Yan P J, et al. Active cis-elements of PCNA Promoter in HeLa, HepG2, L-02 and MCF-7 Cell Lines. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2000, 32: 451-458
[138] Yamaguchi M, Hayashi Y, Matsuoka S, et al. Differential effect of p53 on the promoters of mouse DNA polymerase beta gene and proliferating-cell-nuclear-antigen gene. Eur J Biochem, 1994; 221: 227-237
[139] Li Y Y, Wang L, Lu C D, et al. An E2F site in the 5'-promoter region contributes to serum-dependent up-regulation of the human proliferating cell nuclear antigen gene. FEBS Lett, 2003, 544:112-118
[140] Sever-Chroneos Z, Angus S P, Fribourg A F, et al. Retinoblastoma Tumor Suppressor Protein Signals through Inhibition of Cyclin-Dependent Kinase 2 Activity To Disrupt PCNA Function in S Phase. Mol Cell Biol, 2001, 21: 4032 – 4045
[141] Angus S P, Mayhew C N, Solomon D A, et al. RB reversibly inhibits DNA replication via two temporally distinct mechanisms. Mol Cell Biol, 2004, 24: 5404-5420
[142] Dutta A, Ruppert J M, Aster J C, et al. Inhibition of DNA replication factor RPA by p53. Nature (London), 1993, 365: 79-82
[143] Ii T, Satomi Y, Katoh D, et al. Induction of cell cycle arrest and p21CIP1/WAF1 expression in human lung cancer cells by isoliquiritigenin.Cancer Letters, 2004, 207: 27–35
[144] Clasen S, Schulz W A, Gerharz C D, et al. Frequent and heterogeneous expression of cyclin-dependent kinase inhibitor WAF/P21 protein and mRNA in urothelial carcinoma. Br J Caner, 1998, 77(4): 515-521
[145] Zwicker J and Muller R. Cell-cycle regulation of gene expression by transcriptional repression. Trends Genet. 1997, 1: 3-6
[146] Zwicker J, Lucibello F C, Wolfraim LA, et al. Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. EMBO J, 1995, 14: 4514-4524.
[147] Huet X, Rech J, Plet A, et al. Cyclin A expression is under negative transcriptional control during the cell cycle. Mol Cell Biol, 1996, 16: 3789-3798.
[148] Lucibello F C, Truss M, Zwicker J, et al. Periodic cdc25C transcription is mediated by a novel cell cycle-regulated repressor element (CDE). EMBO J, 1995, 14: 132-142
[149] Tommasi S and Pfeifer G P. In vivo structure of the human cdc2 promoter: release of a p130-E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression. Mol Cell Biol, 1995, 15: 6901-6913
[150] Liu N, Lucibello F C, Zwicker J, et al. Cell cycle-regulated repression of B-myb transcription: cooperation of an E2F site with a contiguous corepressor element. Nucleic Acids Res, 1996, 24: 2905-2910
[151] Bennett J D, Farlie P G and Watson R J. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts. Oncogene, 1996, 13: 1073-1082
[152] Uchiumi T, Longo D L and Ferris D K. Cell cycle regulation of the human polo-like kinase (PLK) promoter. J Biol Chem, 1997, 272: 9166-9174
[153] Li F and Altieri D C. The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression. Cancer Res, 1999, 59: 3143-3151
[154] Ren B, Cam H, Takahashi Y, et al. E2F integrates cell cycle progression with DNA repair, replication, and G2/M checkpoints. Genes & Dev, 2002 16: 245-256
[155] Takahashi Y, Rayman J B, and Dynlacht B D. Analysis of promoter binding bythe E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes & Dev, 2000, 14: 804-816
[156] Ishida S, Huang E, Zuzan H, et al. Role for E2F in Control of Both DNA Replication and Mitotic Functions as Revealed from DNA Microarray Analysis. Mol Cell Biol, 2001, 21: 4684 – 4699
[157] Ezhevsky S A, Ho A, Becker-Hapak M, et al. Differential regulation of retinoblastoma tumor suppressor protein by G1 cyclin-dependent kinase complexes in vivo. Mol Cell Biol, 2001, 21: 4773 – 4784
[158] Calbó J, Parre?o M, Sotillo E, et al. G1 Cyclin/Cyclin-dependent Kinase-coordinated phosphorylation of endogenous pocket proteins differentially regulates their interactions with E2F4 and E2F1 and gene expression. J Biol Chem, 2002, 277: 50263 – 50274
[159] Tsutsui T, Hesabi B, Moons D S, et al. Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity. Mol Cell Biol, 1999, 19: 7011-7019
[160] Ekholm-Reed S, Méndez J, Tedesco D, et al. Deregulation of cyclin E in human cells interferes with prereplication complex assembly. J Cell Biol, 2004, 165(6): 789-800
[161] Munna L, Agarwal, William R, et al. The p53 network. J Biol Chem, 1998, 273: 1-4
[162] El-Deiry W S, Tokino T, Velculescu V E, et al. WAF1, a potential mediator of p53 tumor suppression. Cell, 1993, 75(4): 817-825
[163] Kearsey J M, Coates P J, Prescott A R, et al. Gadd45 is a nuclear cell cycle regulated protein which interacts with p21Cip1. Oncogene, 1995, 11(9): 1675-168319
[164] Hall P A, Kearsey J M, Coates P J, et al. Characterisation of the interaction between PCNA and Gadd45. Oncogene, 1995, 10(12): 2427-2433
[165] El-Deiry W S, Tokino T, Velculescu V E, et al. WAF1, a potential mediator of p53 tumor suppression. Cell, 1993, 75: 817–825
[166] Brugarolas J, Chandrasekaran C, Gordon J I, et al. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature, 1995, 377: 552–557
[167] Liang S H and Clarke M F. Regulation of p53 localization. Eur J Biochem, 2001, 268: 2779-2783
[168] Moll U M, Riou G and Levine A J. Distinct mechanisms alter p53 in breastcancer: mutation and nuclear exclusion. PNAS, 1992, 89: 7262 - 7266
[169] Shaulsky G, Ben-Ze'ev A and Rotter V. Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells. Oncogene, 1990, 5: 1707-1711
[170] Katsumoto T, Higaki K, Ohno K, et al. Cell-cycle dependent biosynthesis and localization of p53 protein in untransformed human cells. Biol Cell. 1995, 84(3): 167-173
[171] Smith M L, Chen I T, Zhan Q, et al. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science, 1994, 266: 1376-1380
[172] Harper J W, Adami G R, Wei N, et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 1993, 75(4): 805-816
[173] L?hr K, M?ritz C, Contente A, et al. p21/CDKN1A Mediates Negative Regulation of Transcription by p53. J Biol Chem, 2003, 278: 32507 - 32516
[174] Seoane J, Le H V and Massague J. Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature, 2002, 419: 729-734
[175] Schurtenberger P, Egelhaaf S U, Hindges R, et al. The solution structure of human proliferating cell nuclear antigen (PCNA) and its interaction with other proteins and DNA. J Mol Biol, 1998, 275: 123
[176] Cayrol C, Knibiehler M and Ducommun B. p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Oncogene, 1998, 16: 311 – 320
[177] Chang B D, Watanabe K, Broude E V, et al. Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: Implications for carcinogenesis, senescence, and age-related diseases. PNAS, 2000, 97: 4291 – 4296
[178] Xiong Y, Hannon G J, Zhang H, et al. p21 is a universal inhibitor of cyclin kinases. Nature, 1993, 366: 701-704
[179] Sherr C J and Roberts J M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev, 1999, 13: 1501-1512
[180] Balbín M, Hannon G J, Pendás A M, et al. Functional Analysis of a p21WAF1,CIP1,SDI1 Mutant (Arg94 Trp) Identified in a Human Breast Carcinoma: Evidence that the mutation impairs the ability of p21 to inhibit cyclin-dependent kinases. J Biol Chem, 1996, 271: 15782-15786
[181] Delavaine L and Thangue N B L. Control of E2F activity by p21Waf1/Cip1. Oncogene, 1999, 18: 5381-5392
[182] Kitaura H, Shinshi M, Uchikoshi Y, et al. Reciprocal Regulation viaProtein-Protein Interaction between c-Myc and p21~(cip1/waf1/sdi1) in DNA Replication and Transcription. J Biol Chem, 2000, 275: 10477-10483
[183] Santoni-Rugiu E, Falck J, Mailand N, et al. Involvement of Myc Activity in a G1/S-Promoting Mechanism Parallel to the pRb/E2F Pathway. Molecular and Cellular Biology, 2000, 20(10): 3497-3509
[184] Timchenko N A, Wilde M, Nakanishi M, et al. CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev, 1996, 10: 804-815.
[185] Timchenko N A, Harris T E, Wilde M, et al. CCAAT/enhancer binding protein alpha regulates p21 protein and hepatocyte proliferation in newborn mice. Mol, Cell Biol, 1997, 17: 7353-7361
[183] Wu F Y, Tang Q Q, Chen H, et al. Lytic replication-associated protein (RAP) encoded by Kaposi sarcoma-associated herpesvirus causes p21CIP-1-mediated G1 cell cycle arrest through CCAAT/enhancer-binding protein-alpha. Proc Natl Acad Sci, U S A, 2002, 99: 10683-10688
[186] Liu N, Lucibello F C, Korner K, et al. CDF-1, a novel E2F-unrelated factor, interacts with cell cycle- regulated repressor elements in multiple promoters. Nucleic Acids Res, 1997, 25: 4915 – 4920
[187] Haugwitz U, Wasner M, Wiedmann M, et al. A single cell cycle genes homology region (CHR) controls cell cycle-dependent transcription of the cdc25C phosphatase gene and is able to cooperate with E2F or Sp1/3 sites. Nucleic Acids Res, 2002, 30: 1967 – 1976
[188] Badie C, Itzhaki J E, Sullivan M J, et al. Repression of CDK1 and Other Genes with CDE and CHR Promoter Elements during DNA Damage-Induced G2/M Arrest in Human Cells. Mol Cell Biol, 2000, 20: 2358 – 2366
[2] Stevaux O, Dyson NJ. A revised picture of the E2F transcriptional network and RB function. Curr Opin Cell Biol, 2002 , 14(6): 684-691
[3] Bandura JL, Calvi BR. Duplication of the genome in normal and cancer cell cycles. Cancer Biology & Therapy, 2002, 1(1):8-13
[4] Burgers, P M, Bambara, R A, Campbell, J L, et al. Revised nomenclature for eukaryotic DNA polymerases. 1990, Eur J Biochem, 191: 617–618
[5] Peter M J, Burgers, Eugene V, et al. Eukaryotic DNA polymerases: proposal for a revised nomenclature. J Biol Chem, 2001, 276: 43487 – 43490
[6] Polina V S, Katarayna B, Thomas A K. Functions of eukaryotic DNA polymerase. Science of Aging Knowledge Environment, 2003, 8: 1-11
[7] Byrnes J, Downey K M, Black V L, et al. A new mammalian DNA polymerase with 3’ to 5’ exonuclease activity: DNA polymerase delta. Biochemistry, 1976, 15: 2817-2823
[8] Lee M Y, Tan C K, So A G, et al. Purification of deoxyribonucleic acid polymerase delta from calf thymus: Patial characterization of physical properties. Biochemistry, 1980, 19: 2096-2101
[9] Shevelev I V, Hubscher U. The 3' 5' exonucleases. Nat Rev Mol Cell Biol, 2002, 3(5): 364-376
[10] Lee M Y, Jiang Y, Zhang S J et al. Characterization of human DNA polymerase δ and its immunological relationships with DNA polymerase α and ε. J Biol Chem, 1991, 266: 2423-2429
[11] Lee M Y, Tan C-K, Downey K M and So A G. Further studies on calf thymus DNA polymerase δ purified to homogeneity by a new procedure. Biochemistry, 1984, 23: 1906-1913
[12] Hughes P, Tratner I, Ducoux M, Piard K, et al. Isolation and identification of the third subunit of mammalian DNA polymerase by PCNA-affinity chromatography of mouse FM3A cell extracts. Nucleic Acids Res, 1999, 27: 2108-2114
[13] Liu L, Mo J, Rodriguez-Belmonte E M, et al. Identification of a forth subunit of mammalian DNA polymerase. J. Biol. Chem, 2000, 275: 18739-18744
[14] Podust V N, Chang L S, Ott R, et al. Reconstitution of human DNA polymerasedelta using recombinant baculoviruses: the p12 subunit potentiates DNA polymerizing activity of the four-subunit enzyme. J Biol Chem, 2002, 277: 3894-3901
[15] Li H, Xie B, Zhou Y, et al. Functional roles of p12, the fourth subunit of the human DNA polymerase delta .J Biol Chem, 2006, 10.1074/jbc.M600322200
[16] Peter M J, Burgers and Gerik K J. Structure and processivity of two forms of Saccharomyces cerevisiae DNA polymerase . J Biol Chem, 1998, 273: 19756-19762
[17] Johansson E, Majka J, Burgers P M. Structure of DNA polymerase delta from Saccharomyces cerevisiae. J Biol Chem, 2001, 276: 43824 - 43828
[18] MacNeill S A, Moreno S, Reynolds N, et al. The fission yeast Cdc1 protein, a homologue of the small subunit of DNA polymerase delta,binds to Po13 and Cdc27. EMBO J, 1996, 15:4613-4628
[19] Zuo S, Bermudez V, Zhang G, et al. Structure and Activity Associated with Multiple Forms of Schizosaccharomyces pombe DNA Polymerase . J Biol Chem, 2000, 275: 5153-5162
[20] Reynolds N, Warbrick E, Fantes P A, et al. Essential interaction between the fission yeast DNA polymerase delta subunit Cdc27 and Pcn1 (PCNA) mediated through a C-terminal p21(Cip1)-like PCNA binding motif . EMBO J, 2000, 19: 1108-1118
[21] Hindges R, Hubscher U. DNA polymerase delta, an essential enzyme for DNA transactions. Biol Chem, 1997, 378:345-362
[22] Brautigam C A, Steitz T A. Structural and functional insights provided by crystal structures of DNA polymerases and their substrate complexes. Curr Opin Struct Biol, 1998, 8: 54-63
[23] Yang C L, Chang L S, Zhang P, et al. Molecular cloning of the cDNA for the catalytic subunit of human DNA polymerase delta. Nucleic Acids Res, 1992, 20: 735 – 745
[24] Hao H, Jiang Y, Zhang S J,et al. Structural and functional elationships of human DNA polymerases. Chromosome, 1998, 102: S121-S127
[25] Zhang S J, Zeng X R, Zhang P, et al. A conserved region in the amino terminus of DNA polymerase delta is involved in proliferating cell nucleat antigen binding. J Biol Chem, 1995, 270: 7988-7992
[26] Hindges R, Hubscher U. Cloning, chromosomal location, and interspeciesinteraction of mouse DNA polymerase delta amall subunit (PolD2). Genomics, 1997, 44: 45-51
[27] Hughes, Tratner I, Ducoux M, et al. Isolation and identification of the third subunit of mammalian DNA polymerase delta by PCNA-affinity chromatography of mouse FM3A cell extracts. Nucleic Acids Res, 1999, 27(10): 2108-2114
[28] Hughes D A, MacNeill S A, Fantes P A. Molecular cloning and sequence analysis of cdc27+ required for the G2-M transition in the fission yeast Schizosaccharomyces prombe. Mol Gen Genet, 1992, 231: 401-410
[29] Gerik K J, Li X, Pautz A, et al. Characterization of the two small subunits of Saccharomyces cerevisiae DNA polymerase delta. J Biol Chem, 1998, 273: 19747-19755
[30] Mo J, Liu L, Leon A, et al. Evidence that DNA polymerase delta isolated by inmmunoaffinity chromatography exhibits high-molecular weight characteristics and is associated with the KIAA0399 protein and RPA. Biochemistry, 2000, 39: 7245-7254
[31] MacNeill S A, Baldacci G, Burgers P M, et al. A unifiednomenclature for the subunits of eukaryotic DNA polymerase δ. Trends in Biochemical Sci, 2001, 26(1): 16-7
[32] Wang S and Stillman B. Anatomy of a DNA replication fork revealed by reconstitution of SV 40 DNA replication in vitro. Nature, 1994, 369: 207-212
[33] Brown W C, Duncan J A and Campbell J L. Purification and characterization of the Saccharomyces cerevisiae DNA polymerase δ overproduced in Escherichia coli. J Biol Chem, 1993, 268: 982-990
[34] Macneill S A, Moreno S, Reynolds N, et al. The fission yeast Cdc1 protein, a homologue of the small subunit of DNA polymerase δ binds to Pol3 and Cdc27. EMBO J, 1996,15: 4613-4628.
[35] Zlotkin T, Kaufmann G, Jiang Y, et al. DNA polymerase epsilon may be dispensable for SV40- but not cellular-DNA replication. EMBO J, 1996, 15: 2298-2305
[36] Budd M E, Campbell J L. Interrelationships between DNA repair and DNA replication. Mutat Res. 2000, 451(1-2): 241-255
[37] Longley M J, Pierce A J and Modrich P. DNA polymerase delta is required for human mismatch repair in vitro. J Biol Chem, 1997, 272: 10917-10921
[38] Jin Y H, Obert R, Burgers P M, et al. The exonuclease of DNA polymerase delta can substitute for the 5' flap endonuclease Rad27/Fen1 in processing Okazaki fragments and preventing genome instability. Proc Natl Acad Sci, USA, 2001, 98: 5122-5127
[39] Morrison A and Sugino A. The 3'-5' exonucleases of both DNA polymerases delta and epsilon participate in correcting errors of DNA replication in Saccharomyces cerevisiae. Mol Gen Genet, 1994, 242: 289-296
[40] Zeng X R, Jiang Y, Zhang S J, et al. DNA polymerase delta is involved in the cellular response to UV damage in human cells. J Biol Chem, 1994, 269: 13748-13751
[41] Shivji M K, Podust V N, Hubecher U, et al. Nucleotide excision repair DNA synthesis by DNA polymerase epsilon in the presence of PCNA, RFC, and RPA. Biochemistry, 1995, 34: 5011-5017
[42] Budd M E and Campbell J L. DNA polymerases required for repair of UV-induced damage in Saccharomyces cerevisiae. Mol Cell Biol, 1995, 15: 2173-2179
[43] Giot L, Chanet R, Simon M, et al. Involvement of the yeast DNA polymerase delta in DNA repair in vivo. Genetics, 1997, 146: 1239-1251
[44] Blank A, Kim B and Loeb L A. DNA polymerase delta is required for base excision repair of DNA methylation damage in Saccharomyces cerevisiae. Proc Natl Acad Sci, 1994, USA, 91: 9047-9051
[45] Fortini P, Pascucci B, Parlanti E, et al. Different DNA polymerases are involved in the short- and long-patch base excision repair in mammalian cells. Biochemistry, 1998, 37: 3575-3580
[46] Diede S J and Gottschling D E. Telomerase-mediated telomere addition in vivo requires DNA primase and DNA polymerases alpha and delta. Cell, 1999, 99: 723-733
[47] Maloisel L, Bhargava J and Roeder G. S. A Role for DNA Polymerase in Gene Conversion and Crossing Over During Meiosis in Saccharomyces cerevisiae . Genetics, 2004, 167: 1133 – 1142
[48] Loeb L A, Springgate C F, Battula N, Errors in DNA replication as a basis of malignant changes. Cancer Res. 1974, 34: 2311–2321
[49] Loeb L A, Loeb K R and Anderson J P. Multiple mutations and cancer. PNAS, 2003, 100: 776 – 781
[50] Chang L S, Zhao L, Zhu L, et al. Structure of the gene for the catalytic subunit of human DNA polymerase delta (POLD1). Genomics, 1995, 28(3): 411-9
[51] Chung, Zhang J, Tan C, et al. Primary Structure of the Catalytic Subunit of Human DNA Polymerase and Chromosomal Location of the Gene. PNAS, 1991, 88: 11197 – 11201
[52] Flohr T, Dai J C, Buttner J, et al. Detection of mutations in the DNA polymerase delta gene of human sporadic colorectal cancers and colon cancer cell lines. Int J Cancer, 1999, 80(6): 919-29
[53] Goldsby R E, Lawrence N A, Hays L E, et al. Defective DNA polymerase-delta proofreading causes cancer susceptibility in mice. Nat Med, 2001, 7(6): 638-639
[54] Robert E. Goldsby, Laura E. et al. High incidence of epithelial cancers in mice deficient for DNA polymerase proofreading. PNAS, 2002, 99: 15560 – 15565
[55] Martin G M. Genetics and the pathobiology of ageing. Philos Trans R Soc London B Biol Sci, 1997, 352, 1773-1780
[56] Szekely A M, Chen Y H, ZhangC, et al. Werner protein recruits DNA polymerase to the nucleolus. PNAS, 2000, 97: 11365- 11370
[57] Kamath-Loeb A S, Loeb L A, Johansson E, et al. Interactions between the Werner Syndrome helicase and DNA polymerase specifically facilitate copying of tetraplex and hairpin structures of the d (CGG)n trinucleotide repeat sequence. J Biol Chem, 2001, 276: 16439–16446
[58] Tsurimoto T, Shinozaki A, Yano M, et al. Human Werner helicase interacting protein1 (WRNIP1) functions as a novel modulator for DNA polymerase delta. Genes Cells, 2005, 10(1): 13 - 22
[59] Liu L, Rodriguez-Belmonte E M, Mazloum N, et al. Identification of a novel protein, PDIP38, that interacts with the p50 subunit of DNA polymerase delta and proliferating cell nuclear antigen. J Biol Chem, 2003, 278: 10041-10047. Epub 2003, 09.
[60] Xie B, Li H, Wang Q, et al. Further characterization of human DNA polymerase interacting protein 38. J Biol Chem, 2005, 280: 22375 – 22384
[61] Liao G., Huang J, Fixman E D, et al. The epstein-barr virus replication protein BBLF2/3 provides an origin-tethering function through interaction with the zinc finger DNA binding protein ZBRK1 and the KAP-1 corepressor. J Virol, 2005,79, 245-256
[62] Dell'era P, Nicoli S, Peri G, et al. FGF2-induced upregulation of DNA polymerase-delta p12 subunit in endothelial cells. Oncogene, 2005, 24, 1117-1121
[63] Zhao L and Chang L S. The human POLD1 gene: identifictaion of an upstream activitor sequence, activation by Sp1 and Sp3, and cell cycle regulation. J Biol Chem, 1997, 272: 4869 – 4882
[64] Li B and Lee M Y W. Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1. J Biol Chem, 2001, 276: 29729 – 29739
[65] Bell S P and Dutta A et al. DNA replication in eukaryotic cells. Annu Rev Biochem, 2002, 71:333-374
[66] G Maga and Hubscher U. DNA replication machinery: functional characterization of a complex containing DNA polymerase alpha, DNA polymerase delta, and replication factor C suggests an asymmetric DNA polymerase dimer. Biochemistry, 1996, 35: 5764-5777
[67] Arezi B and Kuchta R D. Eukaryotic DNA primase. Trends Biochem Sci, 2000, 25: 572–576
[68] Hübscher U, Maga G and Spadari S. Eukaryotic DNA polymerases. Annu Rev Biochem, 2002, 71:133–163
[69] Takada-Takayama R, Tada S, Hanaoka F, et al. Peptide mapping of the four subunits of the mouse DNA polymerase alpha-primase complex. Biochem Biophys Res Commun, 1990, 170: 589-595
[70] Takada-Takayama R, Suzuki M, Enomoto T, et al. Purification and characterization of mouse DNA polymerase alpha devoid of primase activity. FEBS Lett, 1990, 273: 27-30
[70] Smith R W and Nasheuer H P et al. Control of complex formation of DNA polymerase alpha-primase and cell-free DNA replication by the C-terminal amino acids of the largest subunit p180. FEBS Lett, 2002, 527: 143-146
[72] Mizuno T, Yamagishi K, Miyazawa H, et al. Molecular architecture of the mouse DNA polymerase α-primase complex. Mol Cell Biol, 1999, 19: 7886 – 7896
[73] Ott R D, Rehfuess C, Podust V N, et al.Role of the p68 subunit of human DNA polymerase-primase in simian virus 40 DNA replication. Mol Cell Biol, 2002, 22: 5669 – 5678
[74] Mizuno T, Ito N, Yokoi M, et al. The second-largest subunit of the mouse DNA polymerase α-primase complex facilitates both production and nuclear translocation of the catalytic subunit of DNA polymeraseα. Mol Cell Biol, 1998, 18:3552–3562
[75] Mizuno T, Okamoto T, Yokoi M, et al. Identification of the nuclear localization signal of mouse DNA primase: nuclear transport of p46 subunit is facilitated by interaction with p54 subunit. J Cell Sci, 1996, 109: 2627–2636
[76] Maga G and Hübscher U. Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci, 2003, 116: 3051 – 3060
[77] H Xu, P Zhang, L Liu, and MY Lee. A novel PCNA-binding motif identified by the panning of a random peptide display library. Biochemistry, 2001, 40(14): 4512-4520
[78] Ogura T and Wilkinson A J. AAA+ superfamily ATPases: common structure-diverse function. Genes Cells, 2001, 6, 575–597
[79] Mossi R and Hubscher U. Clamping down on clamps and clamp loaders—the eukaryotic replication factor C. Eur. J. Biochem., 1998, 254, 209–216
[80] Shiomi Y, Usukura J, Masamura Y, et al. ATP-dependent structural change of the eukaryotic clamp-loader protein, replication factor C. Proc Natl Acad Sci, USA , 2000, 97: 14127–14132
[81] Shiomi Y, Shinozaki A, Sugimoto K, et al. The reconstituted human Chl12-RFC complex functions as a second PCNA loader. Genes Cells, 2004, 9(4): 279 – 290
[82] Bermudez V P, Lindsey-Boltz L A, Cesare A J, et al. Loading of the human 9–1–1 checkpoint complex onto DNA by the checkpoint clamp loader hRad17-replication factor C complex in vitro. Proc Natl Acad Sci, USA, 2003, 100: 1633–1638
[83] Kanellis P, Agyei R and Durocher D. Elg1 Forms an Alternative PCNA-Interacting RFC Complex Required to Maintain Genome Stability. Curr Biol, 2003, 13: 1583–1595
[84] McConnell M, Miller H, Mozzherin D J, et al. The mammalian DNA polymerase delta-- proliferating cell nuclear antigen--template-primer complex: molecular characterization by direct binding. Biochemistry, 1996, 35: 8268-8274
[85] O’Day C, Burgers P M J and Taylor J S. PCNA induced DNA synthesis past cis-syn and trans-syn-l thymine dimers by calf thymus DNA polymerase δ in Vitro. Nucleic Acids Research, 1992, 20: 5403-5406
[86] Zhang P, Sun Y, Hsu H, et al. The interdomain connector loop of human PCNA is involved in a direct interaction with human polymerase . J Biol Chem. 1998, 273: 713-719
[87] Zhang P, Mo J Y, Perez A, et al. Direct interaction of proliferating cell nuclear antigen with the p125 catalytic subunit of mammalian DNA polymerase . J Biol Chem, 1999, 274: 26647-26653
[88] Ducoux M, Urbach S, Baldacci G, et al. Mediation of proliferating cell nuclear antigen (PCNA)-dependent DNA replication through a conserved p21Cip1-like PCNA-binding motif present in the third subunit of human DNA polymerase . J Biol Chem, 2001, 276: 49258 – 49266
[89] Lu X, Tan C K, Zhou J Q, et al. Direct interaction of proliferating cell nuclear antigen with the small subunit of DNA polymerase . J Biol Chem, 2002, 277: 24340 - 24345
[90] Li H, Xie B, Zhou Y, et al. Functional roles of p12, the fourth subunit of the human DNA polymerase delta. J Biol Chem, 2006, 10.1074/jbc.M600322200
[91] Waga S and Stillman B. Anatomy of a DNA replication fork revealed by reconstitution of SV40 DNA replication in vitro. Nature, 1994, 369(6477): 207-212
[92] Szuts D, Kitching L, Christov C, et al. RPA is an initiation factor for human chromosomal DNA replication. Nucleic Acids Research, 2003, 31(6): 1725-1734
[93] Maga G, Stucki M, Spadari S, et al. DNA polymerase switching: I. Replication factor C displaces DNA polymerase alpha prior to PCNA loading. J Mol Biol, 2000, 295(4): 791-801
[94] Mossi R, Keller R C, Ferrari E, et al. DNA polymerase switching: II. Replication factor C abrogates primer synthesis by DNA polymerase α at a critical length. J Mol Biol, 2000, 295(4): 803-814
[95] Murante R S, Rumbaugh J A, Barnes C J, et al. Calf RTH-1 Nuclease Can Remove the Initiator RNAs of Okazaki Fragments by Endonuclease Activity. J Biol Chem, 1996, 271: 25888 – 25897
[96] Rumbaugh J A, Murante R S, Shi S, et al. Creation and Removal of Embedded Ribonucleotides in Chromosomal DNA during Mammalian Okazaki Fragment Processing. J Biol Chem, 1997, 272: 22591 - 22599
[97] Zhu F X, Biswas E E and Biswas S B. Purification and characterization of theDNA polymerase alpha associated exonuclease: the RTH1 gene product. Biochemistry, 1997, 36(20): 5947-5954
[98] Turchi J J, Huang L, Murante R S, et al. Enzymatic Completion of Mammalian Lagging-Strand DNA Replication. PNAS, 1994, 91: 9803 - 9807
[99] Maga G, Villani G, Tillement V, et al. Okazaki fragment processing: Modulation of the strand displacement activity of DNA polymerase by the concerted action of replication protein A, proliferating cell nuclear antigen, and flap endonuclease-1. PNAS, 2001, 98: 14298 - 14303
[100] 张艳丽,杨克恭,陈松森. 真核DNA复制机制的研究进展. 生命的化学, 2 0 0 0, 2 0(4): 156-158
[101] Erlandsson F, Linnman C, Ekholm S, et al. A detailed analysis of cyclin A accumulation at the G(1)/S border in normal and transformed cells. Exp Cell Res, 2000, 259(1): 86-95
[102] Pagano M, Pepperkok R, Verde F, et al. Cyclin A is required at two points in the human cell cycle. EMBO J, 1992, 11: 961 – 971
[103] Coverley D, Laman H and Laskey R A. Distinct roles for cyclins E and A during DNA replication complex assembly and activation. Nature Cell Biology,2002, 4: 523-528
[104] Cook J G, Park C H, Burke T W, et al. Analysis of Cdc6 function in the assembly of mammalian prereplication complexes. Proc Natl Acad Sci U S A. 2002, 99(3):1347-1352. Epub 2002 Jan 22
[105] Frouin I, Montecucco A, Biamonti G, et al. Cell cycle-dependent dynamic association of cyclin/CDK complexes with human DNA replication proteins. EMBO J, 2002, 21: 2485 – 2495
[106] Kim T Y and Kaelin W G. Differential Control of Transcription by DNA-bound Cyclins. Mol Biol Cell, 2001, 12: 2207 – 2217
[107] Sellers W R and Kaelin W G. pRB as a modulator of transcription. Biochim Biophys Acta, 1996, 1288(1): M1-5
[108] Bell S P and Dutta A. DNA replication in eukaryotic cells. Annu Rev Biochem, 2002, 71: 333-374
[109] Din S, Brill S J, Fairman M P, et al. Cell-cycle-regulated phosphorylation of DNA replication factor A from human and yeast cells. Genes & Dev, 1990, 4: 968 - 977
[110] Dutta A and Stillman B. cdc2 family kinases phosphorylate a human cell DNAreplication factor, RPA, and activate DNA replication. EMBO J, 1992, 11: 2189 – 2199
[111] Binz S K, Lao Y, Lowry D F, et al. The phosphorylation domain of the 32-kDa subunit of replication protein A (RPA) modulates RPA-DNA interactions: evidence for an intersubunit interaction. J Biol Chem, 2003, 278(37): 35584 – 35591
[112] VassinV M, Wold M S and Borowiec J A. Replication protein A (RPA) phosphorylation prevents RPA association with replication centers. Mol Cell Biol, 2004, 24(5): 1930 – 1943
[113] Dehde S, Rohaldy G, Schub O, et al. Two immunologically distinct human DNA polymerase alpha-primase subpopulations are involved in cellular DNA replication. Mol Cell Biol, 2001, 21, 2581-2593
[114] Voitenleitner C, Rehfuess C, HilmesM, et al. Cell cycle-dependent regulation of human DNA polymerase -primase activity by phosphorylation. Mol Cell Biol, 1999, 19: 646 – 656
[115] Ott R D, Rehfuess C, Podust V N, et al. Role of the p68 subunit of human DNA polymerase {alpha}-primase in simian virus 40 DNA replication. Mol Cell Biol, 2002, 22: 5669-5678
[116] Voitenleitner C, Fanning E and Nasheuer H P. Phosphorylation of DNA polymerase alpha-primase by cyclin A-dependent kinases regulates initiation of DNA replication in vitro. Oncogene , 1997, 14: 1611-1615
[117] Schub O, Rohaly G, Smith R W P, et al. Multiple phosphorylation sites of DNA polymerase alpha-primase cooperate to regulate the initiation of DNA replication in vitro. J Biol Chem, 2001, 276: 38076 - 38083
[118] Koundrioukoff S, Jónsson Z O, Hasan S, et al. A Direct interaction between proliferating cell nuclear antigen (PCNA) and CDK2 targets PCNA-interacting proteins for phosphorylation. J Biol Chem, 2000, 275: 22882 – 22887
[119] Munshi A, Cannella D, Brickner H, et al. Cell cycle-dependent phosphorylation of the large subunit of replication factor C (RF-C) leads to its dissociation from the RF-C complex. J Biol Chem, 2003, 278: 48467-48473
[120] Salles-Passador I, Munshi A, Cannella D, et al. Phosphorylation of the PCNA binding domain of the large subunit of replication factor C on Thr506 by cyclin-dependent kinases regulates binding to PCNA. Nucleic Acids Res, 2003, 31: 5202-5211
[121] Zeng X R, Hao H, Jiang Y, et al. Regulation of human DNA polymerase delta during the cell cycle. J Biol Chem, 1994, 269: 24027 – 24033
[122] Wu S M, Zhang P, Zeng X R, et al. Characterization of the p125 subunit of human DNA polymerase and its deletion mutants: interaction with cyclin-dependent kinase-cyclins. J Biol Chem, 1998, 273: 9561 - 9569
[123] Bashir T, H?rlein R, Rommelaere J, et al. Cyclin A activates the DNA polymerase -dependent elongation machinery in vitro: A parvovirus DNA replication model. PNAS, 2000, 97: 5522 - 5527
[124] Henneke G, Koundrioukoff S, Hubscher U. Phosphorylation of human Fen1 by cyclin-dependent kinase modulates its role in replication fork regulation. Oncogene, 2003, 22(28): 4301-4313
[125] Henneke G, Koundrioukoff S and Hübscher U. Multiple roles for kinases in DNA replication. EMBO Rep, 2003, 4: 252 – 256
[126] Ferrari G, Rossi R, Arosio D, et al. Cell cycle-dependent phosphorylation of human DNA ligase I at the cyclin-dependent kinase sites. J Biol Chem, 2003, 278: 37761 - 37767
[127] Kalma Y, Marash L, Lamed Y, et al. Expression analysis using DNA microarrays demonstrates that E2F-1 up-regulates expression of DNA replication genes including replication protein A2. Oncogene, 2001, 20:1379-1387
[128] Izumi M, Yokoi M, Nishikawa N S, et al. Transcription of the catalytic 180-kDa subunit gene of mouse DNA polymerase alpha is controlled by E2F, an Ets-related transcription factor, and Sp1. Biochim Biophys Acta, 2000, 1492: 341-352
[129] Nishikawa N S, Izumi M, Uchida H, et al. Cloning and characterization of the 5'-upstream sequence governing the cell cycle-dependent transcription of mouse DNA polymerase 68 kDa subunit gene Nucleic Acids Research, 2000, 28, 1525-1534
[130] Matsuo K, Shintani S, Tsuji T, et al. p12DOC-1, a growth suppressor, associates with DNA polymerase /primase. FASEB J, 2000, 14: 1318 – 1324
[131] Takemura M, Yamamoto T, Kitagawa M, et al. Stimulation of DNA polymerase alpha activity by cdk2-phosphorylated Rb protein. Biochem Biophys Res Commun, 2001, 282: 984-990
[132] Huang P. Excision of mismatched nucleotides from DNA: a potentialmechanism for enhancing DNA replication fidelity by the wild-type p53 protein. Oncogene, 1998, 17: 261-270
[133] Kuhn C, Muller F, Melle C, et al. Surface plasmon resonance measurements reveal stable complex formation between p53 and DNA polymerase alpha. Oncogene, 1999, 18: 769-774
[134] Melle C and Nasheuer H P. Physical and functional interactions of the tumor suppressor protein p53 and DNA polymerase α-primase. Nucleic Acids Res, 2002, 30: 1493 – 1499
[135] Krucher N A, Zygmunt A, Mazloum N, et al. Interaction of the retinoblastoma protein (pRb) with the catalytic subunit of DNA polymerase delta (p125). Oncogene, 2000, 19: 5464-5470
[136] Morris G F, Bischoff J R and Mathews M B. Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53. Proc Natl Acad Sci USA, 1996, 93: 895 – 899
[137] Wang L, Li M, Yan P J, et al. Active cis-elements of PCNA Promoter in HeLa, HepG2, L-02 and MCF-7 Cell Lines. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2000, 32: 451-458
[138] Yamaguchi M, Hayashi Y, Matsuoka S, et al. Differential effect of p53 on the promoters of mouse DNA polymerase beta gene and proliferating-cell-nuclear-antigen gene. Eur J Biochem, 1994; 221: 227-237
[139] Li Y Y, Wang L, Lu C D, et al. An E2F site in the 5'-promoter region contributes to serum-dependent up-regulation of the human proliferating cell nuclear antigen gene. FEBS Lett, 2003, 544:112-118
[140] Sever-Chroneos Z, Angus S P, Fribourg A F, et al. Retinoblastoma Tumor Suppressor Protein Signals through Inhibition of Cyclin-Dependent Kinase 2 Activity To Disrupt PCNA Function in S Phase. Mol Cell Biol, 2001, 21: 4032 – 4045
[141] Angus S P, Mayhew C N, Solomon D A, et al. RB reversibly inhibits DNA replication via two temporally distinct mechanisms. Mol Cell Biol, 2004, 24: 5404-5420
[142] Dutta A, Ruppert J M, Aster J C, et al. Inhibition of DNA replication factor RPA by p53. Nature (London), 1993, 365: 79-82
[143] Ii T, Satomi Y, Katoh D, et al. Induction of cell cycle arrest and p21CIP1/WAF1 expression in human lung cancer cells by isoliquiritigenin.Cancer Letters, 2004, 207: 27–35
[144] Clasen S, Schulz W A, Gerharz C D, et al. Frequent and heterogeneous expression of cyclin-dependent kinase inhibitor WAF/P21 protein and mRNA in urothelial carcinoma. Br J Caner, 1998, 77(4): 515-521
[145] Zwicker J and Muller R. Cell-cycle regulation of gene expression by transcriptional repression. Trends Genet. 1997, 1: 3-6
[146] Zwicker J, Lucibello F C, Wolfraim LA, et al. Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. EMBO J, 1995, 14: 4514-4524.
[147] Huet X, Rech J, Plet A, et al. Cyclin A expression is under negative transcriptional control during the cell cycle. Mol Cell Biol, 1996, 16: 3789-3798.
[148] Lucibello F C, Truss M, Zwicker J, et al. Periodic cdc25C transcription is mediated by a novel cell cycle-regulated repressor element (CDE). EMBO J, 1995, 14: 132-142
[149] Tommasi S and Pfeifer G P. In vivo structure of the human cdc2 promoter: release of a p130-E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression. Mol Cell Biol, 1995, 15: 6901-6913
[150] Liu N, Lucibello F C, Zwicker J, et al. Cell cycle-regulated repression of B-myb transcription: cooperation of an E2F site with a contiguous corepressor element. Nucleic Acids Res, 1996, 24: 2905-2910
[151] Bennett J D, Farlie P G and Watson R J. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts. Oncogene, 1996, 13: 1073-1082
[152] Uchiumi T, Longo D L and Ferris D K. Cell cycle regulation of the human polo-like kinase (PLK) promoter. J Biol Chem, 1997, 272: 9166-9174
[153] Li F and Altieri D C. The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression. Cancer Res, 1999, 59: 3143-3151
[154] Ren B, Cam H, Takahashi Y, et al. E2F integrates cell cycle progression with DNA repair, replication, and G2/M checkpoints. Genes & Dev, 2002 16: 245-256
[155] Takahashi Y, Rayman J B, and Dynlacht B D. Analysis of promoter binding bythe E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes & Dev, 2000, 14: 804-816
[156] Ishida S, Huang E, Zuzan H, et al. Role for E2F in Control of Both DNA Replication and Mitotic Functions as Revealed from DNA Microarray Analysis. Mol Cell Biol, 2001, 21: 4684 – 4699
[157] Ezhevsky S A, Ho A, Becker-Hapak M, et al. Differential regulation of retinoblastoma tumor suppressor protein by G1 cyclin-dependent kinase complexes in vivo. Mol Cell Biol, 2001, 21: 4773 – 4784
[158] Calbó J, Parre?o M, Sotillo E, et al. G1 Cyclin/Cyclin-dependent Kinase-coordinated phosphorylation of endogenous pocket proteins differentially regulates their interactions with E2F4 and E2F1 and gene expression. J Biol Chem, 2002, 277: 50263 – 50274
[159] Tsutsui T, Hesabi B, Moons D S, et al. Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity. Mol Cell Biol, 1999, 19: 7011-7019
[160] Ekholm-Reed S, Méndez J, Tedesco D, et al. Deregulation of cyclin E in human cells interferes with prereplication complex assembly. J Cell Biol, 2004, 165(6): 789-800
[161] Munna L, Agarwal, William R, et al. The p53 network. J Biol Chem, 1998, 273: 1-4
[162] El-Deiry W S, Tokino T, Velculescu V E, et al. WAF1, a potential mediator of p53 tumor suppression. Cell, 1993, 75(4): 817-825
[163] Kearsey J M, Coates P J, Prescott A R, et al. Gadd45 is a nuclear cell cycle regulated protein which interacts with p21Cip1. Oncogene, 1995, 11(9): 1675-168319
[164] Hall P A, Kearsey J M, Coates P J, et al. Characterisation of the interaction between PCNA and Gadd45. Oncogene, 1995, 10(12): 2427-2433
[165] El-Deiry W S, Tokino T, Velculescu V E, et al. WAF1, a potential mediator of p53 tumor suppression. Cell, 1993, 75: 817–825
[166] Brugarolas J, Chandrasekaran C, Gordon J I, et al. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature, 1995, 377: 552–557
[167] Liang S H and Clarke M F. Regulation of p53 localization. Eur J Biochem, 2001, 268: 2779-2783
[168] Moll U M, Riou G and Levine A J. Distinct mechanisms alter p53 in breastcancer: mutation and nuclear exclusion. PNAS, 1992, 89: 7262 - 7266
[169] Shaulsky G, Ben-Ze'ev A and Rotter V. Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells. Oncogene, 1990, 5: 1707-1711
[170] Katsumoto T, Higaki K, Ohno K, et al. Cell-cycle dependent biosynthesis and localization of p53 protein in untransformed human cells. Biol Cell. 1995, 84(3): 167-173
[171] Smith M L, Chen I T, Zhan Q, et al. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science, 1994, 266: 1376-1380
[172] Harper J W, Adami G R, Wei N, et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 1993, 75(4): 805-816
[173] L?hr K, M?ritz C, Contente A, et al. p21/CDKN1A Mediates Negative Regulation of Transcription by p53. J Biol Chem, 2003, 278: 32507 - 32516
[174] Seoane J, Le H V and Massague J. Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature, 2002, 419: 729-734
[175] Schurtenberger P, Egelhaaf S U, Hindges R, et al. The solution structure of human proliferating cell nuclear antigen (PCNA) and its interaction with other proteins and DNA. J Mol Biol, 1998, 275: 123
[176] Cayrol C, Knibiehler M and Ducommun B. p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Oncogene, 1998, 16: 311 – 320
[177] Chang B D, Watanabe K, Broude E V, et al. Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: Implications for carcinogenesis, senescence, and age-related diseases. PNAS, 2000, 97: 4291 – 4296
[178] Xiong Y, Hannon G J, Zhang H, et al. p21 is a universal inhibitor of cyclin kinases. Nature, 1993, 366: 701-704
[179] Sherr C J and Roberts J M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev, 1999, 13: 1501-1512
[180] Balbín M, Hannon G J, Pendás A M, et al. Functional Analysis of a p21WAF1,CIP1,SDI1 Mutant (Arg94 Trp) Identified in a Human Breast Carcinoma: Evidence that the mutation impairs the ability of p21 to inhibit cyclin-dependent kinases. J Biol Chem, 1996, 271: 15782-15786
[181] Delavaine L and Thangue N B L. Control of E2F activity by p21Waf1/Cip1. Oncogene, 1999, 18: 5381-5392
[182] Kitaura H, Shinshi M, Uchikoshi Y, et al. Reciprocal Regulation viaProtein-Protein Interaction between c-Myc and p21~(cip1/waf1/sdi1) in DNA Replication and Transcription. J Biol Chem, 2000, 275: 10477-10483
[183] Santoni-Rugiu E, Falck J, Mailand N, et al. Involvement of Myc Activity in a G1/S-Promoting Mechanism Parallel to the pRb/E2F Pathway. Molecular and Cellular Biology, 2000, 20(10): 3497-3509
[184] Timchenko N A, Wilde M, Nakanishi M, et al. CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev, 1996, 10: 804-815.
[185] Timchenko N A, Harris T E, Wilde M, et al. CCAAT/enhancer binding protein alpha regulates p21 protein and hepatocyte proliferation in newborn mice. Mol, Cell Biol, 1997, 17: 7353-7361
[183] Wu F Y, Tang Q Q, Chen H, et al. Lytic replication-associated protein (RAP) encoded by Kaposi sarcoma-associated herpesvirus causes p21CIP-1-mediated G1 cell cycle arrest through CCAAT/enhancer-binding protein-alpha. Proc Natl Acad Sci, U S A, 2002, 99: 10683-10688
[186] Liu N, Lucibello F C, Korner K, et al. CDF-1, a novel E2F-unrelated factor, interacts with cell cycle- regulated repressor elements in multiple promoters. Nucleic Acids Res, 1997, 25: 4915 – 4920
[187] Haugwitz U, Wasner M, Wiedmann M, et al. A single cell cycle genes homology region (CHR) controls cell cycle-dependent transcription of the cdc25C phosphatase gene and is able to cooperate with E2F or Sp1/3 sites. Nucleic Acids Res, 2002, 30: 1967 – 1976
[188] Badie C, Itzhaki J E, Sullivan M J, et al. Repression of CDK1 and Other Genes with CDE and CHR Promoter Elements during DNA Damage-Induced G2/M Arrest in Human Cells. Mol Cell Biol, 2000, 20: 2358 – 2366